BCYC - Wall Street Estimates - Bicycle Therapeutics plc

Healthcare - Biotechnology - NASDAQ - GB

$ 13.42

5.09 %

$ 926 M

Market Cap

-4.09

P/E

Price Target Average

192.47%

Revenue Forecast Estimate

136.51%

EBIT Estimate

--23.40%

Net Income Estimate

28.66%

WALL STREET ESTIMATES

Wall Street Analysts Price Targets Bicycle Therapeutics plc

Wall Street analysts predict an average 1-year price target for BCYC of $39.2 , with forecasts ranging from a low of $26 to a high of $55 .

BCYC Lowest Price Target Wall Street Target

26 USD 93.74%

BCYC Average Price Target Wall Street Target

39.2 USD 192.47%

BCYC Highest Price Target Wall Street Target

55 USD 309.84%

REVENUE FORECAST

EBIT FORECAST

NET INCOME FORECAST

Free